시장보고서
상품코드
1581861

헤지호그 경로 억제제 시장(2024-2028년)

Global Hedgehog Pathway Inhibitors Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 143 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헤지호그 경로 억제제 시장은 2023-2028년간 3억 4,120만 달러 확대되고, 예측 기간 중에 11.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다. 헤지호그 경로 억제제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개사 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 이 시장은 BCC·AML의 고리스크 요인, 고령자 인구 증가, BCC나 AML에 관한 의식 고양에 의해 성장이 촉진되고 있습니다.

시장 범위
기준년 2024년
종료년 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
전년대비(2024년) 10.7%
CAGR 11.8%
증분액 3억 4,120만 달러

리파파스 제제 개발을 향후 몇 년간 헤지호그 경로 억제제 시장 성장을 가속하는 주요인 중 하나로 특정하고 있습니다. 또한 전략적 제휴나 암 관련 연구에 대한 자금 제공이 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계
  • 시장 특징
  • 밸류체인 분석

제3장 시장 규모 평가

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제4장 시장 규모 실적

  • 헤지호그 경로 억제제 시장(2018-2022년)
  • 적응증별 분석(2018-2022년)
  • 지역별 분석(2018-2022년)
  • 국가별 분석(2018-2022년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 시장 세분화 : 적응증별

  • 시장 세분화
  • 비교 : 적응증별
  • BCC(기저세포암) : 시장 규모와 예측(2023-2028년)
  • AML(급성 골수성 백혈병) : 시장 규모와 예측(2023-2028년)
  • 적응증별 시장 기회

제7장 고객 상황

  • 고객 상황 개요

제8장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 캐나다 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 지역별 시장 기회

제9장 성장 촉진요인, 과제, 기회 및 성장 억제요인

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회와 성장 억제요인

제10장 경쟁 구도

  • 개요
  • 경쟁 구도
  • 혼란 상황
  • 업계 리스크

제11장 경쟁 분석

  • 기업 개요
  • 기업의 시장 포지셔닝
  • BridgeBio Pharma Inc
  • Bristol Myers Squibb Co.
  • F. Hoffmann La Roche Ltd.
  • INHIBITOR Therapeutics Inc.
  • MAX BioPharma Inc.
  • Mayne Pharma Group Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

제12장 부록

LSH 24.11.21

Hedgehog Pathway Inhibitors Market 2024-2028

The hedgehog pathway inhibitors market is forecasted to grow by USD 341.2 mn during 2023-2028, accelerating at a CAGR of 11.8% during the forecast period. The report on the hedgehog pathway inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high-risk factors for bcc and aml, growth of geriatric population, and increasing awareness about bcc and aml.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202410.7%
CAGR11.8%
Incremental Value$341.2 mn

Technavio's hedgehog pathway inhibitors market is segmented as below:

By Indication

    • BCC
    • AML

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the development of repurposed formulations as one of the prime reasons driving the hedgehog pathway inhibitors market growth during the next few years. Also, strategic alliances and funding for cancer-related research will lead to sizable demand in the market.

The report on the hedgehog pathway inhibitors market covers the following areas:

    • Hedgehog Pathway Inhibitors Market sizing
    • Hedgehog Pathway Inhibitors Market forecast
    • Hedgehog Pathway Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hedgehog pathway inhibitors market vendors that include BridgeBio Pharma Inc, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., INHIBITOR Therapeutics Inc., MAX BioPharma Inc., Mayne Pharma Group Ltd., Novartis AG, Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd.. Also, the hedgehog pathway inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Indication
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Hedgehog Pathway Inhibitors Market 2018 - 2022
    • Historic Market Size - Data Table on Global Hedgehog Pathway Inhibitors Market 2018 - 2022 ($ million)
  • 4.2 Indication segment analysis 2018 - 2022
    • Historic Market Size - Indication Segment 2018 - 2022 ($ million)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Indication

  • 6.1 Market segments
    • Chart on Indication - Market share 2023-2028 (%)
    • Data Table on Indication - Market share 2023-2028 (%)
  • 6.2 Comparison by Indication
    • Chart on Comparison by Indication
    • Data Table on Comparison by Indication
  • 6.3 BCC - Market size and forecast 2023-2028
    • Chart on BCC - Market size and forecast 2023-2028 ($ million)
    • Data Table on BCC - Market size and forecast 2023-2028 ($ million)
    • Chart on BCC - Year-over-year growth 2023-2028 (%)
    • Data Table on BCC - Year-over-year growth 2023-2028 (%)
  • 6.4 AML - Market size and forecast 2023-2028
    • Chart on AML - Market size and forecast 2023-2028 ($ million)
    • Data Table on AML - Market size and forecast 2023-2028 ($ million)
    • Chart on AML - Year-over-year growth 2023-2028 (%)
    • Data Table on AML - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Indication
    • Market opportunity by Indication ($ million)
    • Data Table on Market opportunity by Indication ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 8.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 8.10 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 8.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 BridgeBio Pharma Inc
    • BridgeBio Pharma Inc - Overview
    • BridgeBio Pharma Inc - Product / Service
    • BridgeBio Pharma Inc - Key offerings
  • 11.4 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 11.5 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 11.6 INHIBITOR Therapeutics Inc.
    • INHIBITOR Therapeutics Inc. - Overview
    • INHIBITOR Therapeutics Inc. - Product / Service
    • INHIBITOR Therapeutics Inc. - Key offerings
  • 11.7 MAX BioPharma Inc.
    • MAX BioPharma Inc. - Overview
    • MAX BioPharma Inc. - Product / Service
    • MAX BioPharma Inc. - Key offerings
  • 11.8 Mayne Pharma Group Ltd.
    • Mayne Pharma Group Ltd. - Overview
    • Mayne Pharma Group Ltd. - Business segments
    • Mayne Pharma Group Ltd. - Key news
    • Mayne Pharma Group Ltd. - Key offerings
    • Mayne Pharma Group Ltd. - Segment focus
  • 11.9 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 11.10 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 11.11 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
  • 11.12 Sun Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd. - Overview
    • Sun Pharmaceutical Industries Ltd. - Product / Service
    • Sun Pharmaceutical Industries Ltd. - Key news
    • Sun Pharmaceutical Industries Ltd. - Key offerings

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
  • 12.9 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제